Cargando…

Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer

Tamoxifen is a drug commonly used in the treatment of breast cancer, especially for postmenopausal patients. However, its efficacy is limited by the development of drug resistance. Downregulation of estrogen receptor alpha (ERα) is an important mechanism of tamoxifen resistance. In recent years, wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Jingwei, Deng, Kun, Huang, Jialu, Zeng, Ruimin, Zuo, Jianhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758911/ https://www.ncbi.nlm.nih.gov/pubmed/33362547 http://dx.doi.org/10.3389/fphar.2020.592912

Ejemplares similares

Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy
por: Deng, Kun, et al.
Publicado: (2021)

PKM2–c-Myc–Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer
por: Yu, Pian, et al.
Publicado: (2020)

Interactions Between Natural Products and Tamoxifen in Breast Cancer: A Comprehensive Literature Review
por: Yen, Christine, et al.
Publicado: (2022)

Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites
por: Khalaj, Zahra, et al.
Publicado: (2019)

Molecular mechanisms and mode of tamoxifen resistance in breast cancer
por: Ali, Shazia, et al.
Publicado: (2016)

Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer
por: Abdel-Hafiz, Hany A.
Publicado: (2017)

Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients
por: Miranda, Carla, et al.
Publicado: (2021)

Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012)

Transcriptional coregualtor NUPR1 maintains tamoxifen resistance in breast cancer cells
por: Wang, Lingling, et al.
Publicado: (2021)

Research Progress and Direction of Novel Organelle—Migrasomes
por: Zhang, Yu, et al.
Publicado: (2022)

Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen
por: Schroth, Werner, et al.
Publicado: (2017)

Tamoxifen from Failed Contraceptive Pill to Best-Selling Breast Cancer Medicine: A Case-Study in Pharmaceutical Innovation
por: Quirke, Viviane M.
Publicado: (2017)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials
por: Li, Hao-Tian, et al.
Publicado: (2018)

The mechanism of tamoxifen in breast cancer prevention
por: Yu, F, et al.
Publicado: (2001)

Nationwide Case-Control Study Examining the Association between Tamoxifen Use and Alzheimer’s Disease in Aged Women with Breast Cancer in Taiwan
por: Liao, Kuan-Fu, et al.
Publicado: (2017)

Polysaccharide Peptide Extract From Coriolus versicolor Increased T(max) of Tamoxifen and Maintained Biochemical Serum Parameters, With No Change in the Metabolism of Tamoxifen in the Rat
por: Razmovski-Naumovski, Valentina, et al.
Publicado: (2022)

Tamoxifen Twists Again: On and Off-Targets in Macrophages and Infections
por: Sfogliarini, Chiara, et al.
Publicado: (2022)

Adjuvant effects of Chinese medicinal tonics on gastric, liver, and colorectal cancers—OMICs-based contributions to understanding their mechanism of action
por: Zuo, Zhigang, et al.
Publicado: (2022)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

Tamoxifen Use Correlates with Increased Risk of the First Episode of Ischemic Cerebrovascular Disease in Older Women with Breast Cancer: A Case-Control Study in Taiwan
por: Lai, Shih-Wei, et al.
Publicado: (2017)

Long-Term Use of Tamoxifen Is Associated With a Decreased Subsequent Meningioma Risk in Patients With Breast Cancer: A Nationwide Population-Based Cohort Study
por: Sun, Li-Min, et al.
Publicado: (2019)

PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies
por: Wang, Nannan, et al.
Publicado: (2022)

Physiologically Based Pharmacokinetic Modeling of Tamoxifen and its Metabolites in Women of Different CYP2D6 Phenotypes Provides New Insight into the Tamoxifen Mass Balance
por: Dickschen, Kristin, et al.
Publicado: (2012)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors
por: Mu, Qingchun, et al.
Publicado: (2021)

Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
por: Li, Zhen, et al.
Publicado: (2020)

Understanding the Emerging Link Between Circadian Rhythm, Nrf2 Pathway, and Breast Cancer to Overcome Drug Resistance
por: Bevinakoppamath, Supriya, et al.
Publicado: (2022)

TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer
por: Wang, Ming-Yang, et al.
Publicado: (2019)

Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells
por: Lv, Chao, et al.
Publicado: (2022)

Phosphorylation of estrogen receptor α at serine 118 is correlated with breast cancer resistance to tamoxifen
por: CHEN, MING, et al.
Publicado: (2013)

Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms
por: Huang, Songyin, et al.
Publicado: (2019)

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
por: Guo, Hehua, et al.
Publicado: (2023)

An epigenomic approach to therapy for tamoxifen-resistant breast cancer
por: Feng, Qin, et al.
Publicado: (2014)

Association of tamoxifen resistance and lipid reprogramming in breast cancer
por: Hultsch, Susanne, et al.
Publicado: (2018)

Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy
por: Zhang, Minghui, et al.
Publicado: (2022)

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
por: Wu, Xiaofan, et al.
Publicado: (2022)

Genomic Understanding Reveals the Important Role of FGFR2 as Paeoniflorin Target for Circumventing Breast Cancer Resistance to Tamoxifen
por: Wibowo, Moh Arikus, et al.
Publicado: (2021)

A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy
por: Botti, Valeria, et al.
Publicado: (2022)

Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance
por: Bekele, Raie T., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ujlppv3ii9mtns13kd63frpr7d